1-20 of 24
Xavier Pi-Sunyer, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study

L. Maria Belalcazar, MD, David M. Reboussin, PHD, Steven M. Haffner, MD, Ron C. Hoogeveen, PHD, Andrea M. Kriska, PHD, Dawn C. Schwenke, PHD, Russell P. Tracy, PHD, F. Xavier Pi-Sunyer, MD, Christie M. Ballantyne, MD, for the Look AHEAD Research Group
Journal: Diabetes Care
Diabetes Care 2010;33(11):2297–2303
https://doi.org/10.2337/dc10-0728
Published: 03 August 2010
View article titled, A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: <subtitle>From the Look AHEAD (Action for Health in Diabetes) study</subtitle>
Open the PDF for A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: <subtitle>From the Look AHEAD (Action for Health in Diabetes) study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes

Mariana Lazo, MD, SCM, Steven F. Solga, MD, Alena Horska, PHD, Susanne Bonekamp, DVM, Anna Mae Diehl, MD, Frederick L. Brancati, MD, MHS, Lynne E. Wagenknecht, DRPH, F. Xavier Pi-Sunyer, MD, MPH, Steven E. Kahn, MB, CHB, Jeanne M. Clark, MD, MPH, for the Fatty Liver Subgroup of the Look AHEAD Research Group
Journal: Diabetes Care
Diabetes Care 2010;33(10):2156–2163
https://doi.org/10.2337/dc10-0856
Published: 27 July 2010
View article titled, Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
Open the PDF for Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study

L. Maria Belalcazar, MD, David M. Reboussin, PHD, Steven M. Haffner, MD, Rebecca S. Reeves, DRPH, Dawn C. Schwenke, PHD, Ron C. Hoogeveen, PHD, F. Xavier Pi-Sunyer, MD, Christie M. Ballantyne, MD, for the Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group
Journal: Diabetes Care
Diabetes Care 2010;33(1):197–199
https://doi.org/10.2337/dc09-1235
Published: 19 October 2009
View article titled, Marine ω-3 Fatty Acid Intake: <subtitle>Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study</subtitle>
Open the PDF for Marine ω-3 Fatty Acid Intake: <subtitle>Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes

Gary D. Foster, PHD, Mark H. Sanders, MD, Richard Millman, MD, Gary Zammit, PHD, Kelley E. Borradaile, PHD, Anne B. Newman, MD, Thomas A. Wadden, PHD, David Kelley, MD, Rena R. Wing, PHD, F. Xavier Pi Sunyer, MD, Valerie Darcey, MS, Samuel T. Kuna, MD, for the Sleep AHEAD Research Group
Journal: Diabetes Care
Diabetes Care 2009;32(6):1017–1019
https://doi.org/10.2337/dc08-1776
Published: 11 March 2009
View article titled, Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes
Open the PDF for Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program

Luc Van Gaal, MD, Xavier Pi-Sunyer, MD, Jean-Pierre Després, PHD, Christine McCarthy, MD, André Scheen, MD
Journal: Diabetes Care
Diabetes Care 2008;31(Supplement_2):S229–S240
https://doi.org/10.2337/dc08-s258
Published: 01 February 2008
View article titled, Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: <subtitle>Pooled 1-year data from the Rimonabant in Obesity (RIO) program</subtitle>
Open the PDF for Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: <subtitle>Pooled 1-year data from the Rimonabant in Obesity (RIO) program</subtitle> in another window
Journal Articles

Management of Type 2 Diabetes in Treatment-Naive Elderly Patients: Benefits and risks of vildagliptin monotherapy

Richard E. Pratley, MD, Julio Rosenstock, MD, F. Xavier Pi-Sunyer, MD, Mary Ann Banerji, MD, Anja Schweizer, PHD, Andre Couturier, MSC, Sylvie Dejager, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(12):3017–3022
https://doi.org/10.2337/dc07-1188
Published: 01 December 2007
View article titled, Management of Type 2 Diabetes in Treatment-Naive Elderly Patients: <subtitle>Benefits and risks of vildagliptin monotherapy</subtitle>
Open the PDF for Management of Type 2 Diabetes in Treatment-Naive Elderly Patients: <subtitle>Benefits and risks of vildagliptin monotherapy</subtitle> in another window
Includes: Supplementary data
Journal Articles

Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes

Richard F. Hamman, MD, DRPH, Rena R. Wing, PHD, Sharon L. Edelstein, SCM, John M. Lachin, SCD, George A. Bray, MD, Linda Delahanty, MS, RD, Mary Hoskin, MS, RD, Andrea M. Kriska, PHD, Elizabeth J. Mayer-Davis, PHD, Xavier Pi-Sunyer, MD, Judith Regensteiner, PHD, Beth Venditti, PHD, Judith Wylie-Rosett, EDD, RD, for the Diabetes Prevention Program Research Group
Journal: Diabetes Care
Diabetes Care 2006;29(9):2102–2107
https://doi.org/10.2337/dc06-0560
Published: 01 September 2006
View article titled, Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes
Open the PDF for Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes in another window
Journal Articles

Do Glycemic Index, Glycemic Load, and Fiber Play a Role in Insulin Sensitivity, Disposition Index, and Type 2 Diabetes?

Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 2005;28(12):2978–2979
https://doi.org/10.2337/diacare.28.12.2978
Published: 01 December 2005
View article titled, Do Glycemic Index, Glycemic Load, and Fiber Play a Role in Insulin Sensitivity, Disposition Index, and Type 2 Diabetes?
Open the PDF for Do Glycemic Index, Glycemic Load, and Fiber Play a Role in Insulin Sensitivity, Disposition Index, and Type 2 Diabetes? in another window
Journal Articles

Weight Loss in Type 2 Diabetic Patients

F. Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 2005;28(6):1526–1527
https://doi.org/10.2337/diacare.28.6.1526
Published: 01 June 2005
View article titled, Weight Loss in Type 2 Diabetic Patients
Open the PDF for Weight Loss in Type 2 Diabetic Patients in another window
Journal Articles

Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes: A statement by the American Diabetes Association

Nancy F. Sheard, SCD, RD, Nathaniel G. Clark, MD, MS, RD, Janette C. Brand-Miller, PHD, Marion J. Franz, MS, RD, CDE, F. Xavier Pi-Sunyer, MD, MPH, Elizabeth Mayer-Davis, PHD, RD, Karmeen Kulkarni, MS, RD, CDE, BC-ADM, Patti Geil, MS, RD, FADA, CDE
Journal: Diabetes Care
Diabetes Care 2004;27(9):2266–2271
https://doi.org/10.2337/diacare.27.9.2266
Published: 01 September 2004
View article titled, Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes: <subtitle>A statement by the American Diabetes Association </subtitle>
Open the PDF for Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes: <subtitle>A statement by the American Diabetes Association </subtitle> in another window
Journal Articles

Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition

Samuel Klein, MD, Nancy F. Sheard, SCD, RD, Xavier Pi-Sunyer, MD, MPH, Anne Daly, MS, RD, BC-ADM, CDE, Judith Wylie-Rosett, EDD, RD, Karmeen Kulkarni, MS, RD, BC-ADM, CDE, Nathaniel G. Clark, MD, MS, RD
Journal: Diabetes Care
Diabetes Care 2004;27(8):2067–2073
https://doi.org/10.2337/diacare.27.8.2067
Published: 01 August 2004
View article titled, Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: <subtitle>A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition </subtitle>
Open the PDF for Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: <subtitle>A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition </subtitle> in another window
Journal Articles

Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes: A 1-year randomized controlled trial

David E. Kelley, MD, George A. Bray, MD, F. Xavier Pi-Sunyer, MD, Samuel Klein, MD, James Hill, PHD, John Miles, MD, Priscilla Hollander, MD, PHD
Journal: Diabetes Care
Diabetes Care 2002;25(6):1033–1041
https://doi.org/10.2337/diacare.25.6.1033
Published: 01 June 2002
View article titled, Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes: <subtitle>A 1-year randomized controlled trial </subtitle>
Open the PDF for Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes: <subtitle>A 1-year randomized controlled trial </subtitle> in another window
Journal Articles

The Prevention and Treatment of Obesity: Application to type 2 diabetes

Carol A Maggio, PHD, F Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 1997;20(11):1744–1766
https://doi.org/10.2337/diacare.20.11.1744
Published: 01 November 1997
View article titled, The Prevention and Treatment of Obesity: Application to type 2 diabetes
Open the PDF for The Prevention and Treatment of Obesity: Application to type 2 diabetes in another window
Journal Articles

The Role of Viscous Soluble Fiber in the Metabolic Control of Diabetes: A review with special emphasis on cereals rich in β-glucan

Pierre Würsch, PHD, F Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 1997;20(11):1774–1780
https://doi.org/10.2337/diacare.20.11.1774
Published: 01 November 1997
View article titled, The Role of Viscous Soluble Fiber in the Metabolic Control of Diabetes: A review with special emphasis on cereals rich in β-glucan
Open the PDF for The Role of Viscous Soluble Fiber in the Metabolic Control of Diabetes: A review with special emphasis on cereals rich in β-glucan in another window
Journal Articles

Acarbose in the Treatment of Type I Diabetes

Priscilla Hollander, MD, PHD, Xavier Pi-Sunyer, MD, Robert F Coniff, MD
Journal: Diabetes Care
Diabetes Care 1997;20(3):248–253
https://doi.org/10.2337/diacare.20.3.248
Published: 01 March 1997
View article titled, Acarbose in the Treatment of Type I Diabetes
Open the PDF for Acarbose in the Treatment of Type I Diabetes in another window
Journal Articles

Glycemic Effect of a Single High Oral Dose of the Novel Sweetener Sucralose in Patients With Diabetes

Nicholas H E Mezitis, MD, Carol A Maggio, PHD, Pamela Koch, MS, Arshad Quddoos, MD, David B Allison, PHD, F Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 1996;19(9):1004–1005
https://doi.org/10.2337/diacare.19.9.1004
Published: 01 September 1996
View article titled, Glycemic Effect of a Single High Oral Dose of the Novel Sweetener Sucralose in Patients With Diabetes
Open the PDF for Glycemic Effect of a Single High Oral Dose of the Novel Sweetener Sucralose in Patients With Diabetes in another window
Journal Articles

The Use of Areas Under Curves in Diabetes Research

David B Allison, PHD, Furcy Paultre, Carol Maggio, PHD, Nicholas Mezzitis, MD, F Xavier Pi-Sunyer, MD, MPH
Journal: Diabetes Care
Diabetes Care 1995;18(2):245–250
https://doi.org/10.2337/diacare.18.2.245
Published: 01 February 1995
View article titled, The Use of Areas Under Curves in Diabetes Research
Open the PDF for The Use of Areas Under Curves in Diabetes Research in another window
Journal Articles

Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients

Peter S Johnston, MD, Robert F Coniff, MD, Byron J Hoogwerf, MD, Julio V Santiago, MD, F Xavier Pi-Sunyer, MD, Alice Krol
Journal: Diabetes Care
Diabetes Care 1994;17(1):20–29
https://doi.org/10.2337/diacare.17.1.20
Published: 01 January 1994
View article titled, Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients
Open the PDF for Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients in another window
Journal Articles

The Mission of the American Diabetes Association: 1993 Presidential Address

F Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 1993;16(11):1521–1525
https://doi.org/10.2337/diacare.16.11.1521
Published: 01 November 1993
View article titled, The Mission of the American Diabetes Association: 1993 Presidential Address
Open the PDF for The Mission of the American Diabetes Association: 1993 Presidential Address in another window
Journal Articles

Combination Therapy for NIDDM With Biosynthetic Human Insulin and Glyburide

Nicholas H E Mezitis, MD, Stanley Heshka, PHD, Valerie Saitas, MD, Timothy S Bailey, MD, Rafaella Costa, MD, F Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 1992;15(2):265–269
https://doi.org/10.2337/diacare.15.2.265
Published: 01 February 1992
View article titled, Combination Therapy for NIDDM With Biosynthetic Human Insulin and Glyburide
Open the PDF for Combination Therapy for NIDDM With Biosynthetic Human Insulin and Glyburide in another window